Infantile Colic Clinical Trial
— CocoOfficial title:
Evaluation of the Safety and Efficacy of New Infant Formula and Its Effects on the Gastrointestinal Tolerance (Crying Time) in Infantile Colic: a Double-blind, Randomized, Controlled Intervention Study
NCT number | NCT01721850 |
Other study ID # | HiPP-505092 |
Secondary ID | |
Status | Terminated |
Phase | N/A |
First received | |
Last updated | |
Start date | December 2011 |
Est. completion date | April 2019 |
Verified date | January 2022 |
Source | HiPP GmbH & Co. Vertrieb KG |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The study is conducted to examine the safety and efficacy of a new infant formula and its effects on the gastrointestinal tolerance in infants suffering from colic. Primary hypothesis to be tested is: an infant formula with optimized composition improves colicky symptoms compared to a standard formula.
Status | Terminated |
Enrollment | 169 |
Est. completion date | April 2019 |
Est. primary completion date | April 2019 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | N/A to 60 Days |
Eligibility | Inclusion Criteria: - Healthy term infants - Subjects appropriate for gestational age between 35 and 41 weeks - Subjects between 15-60 days old - Subjects with birth weight between 2500 and 4200 g and regular weight gain (=150g / week) - Diagnosis of infantile colic according to modified Wessel criteria (Crying episodes lasting 3 or more hours/day and occurring at least 3 days/week for at least 1 week) - Subjects exclusively bottle-fed at study entrance - Day care of the child only by mother/father - Provide written informed consent in accordance with legal requirement Exclusion Criteria: - Neonatal problems (respiratory distress, asphyxia, Hypoglycaemia, sepsis, NEC) - Clinical evidence of chronic illness or gastrointestinal disorders (GER, gastroenteritis) - Assumption of any kind of medication (except vitamin D, vitamin K and fluoride prophylaxis) during the week before the beginning of the study and during the study period - Subjects receiving formula for special medical purposes - Exclusively breast-fed infants - Feeding of supplemental Pro- and/or Prebiotics two weeks prior to inclusion - Allergic diseases (manifest atopic dermatitis, cow's milk allergy) - Participation in any other clinical intervention |
Country | Name | City | State |
---|---|---|---|
Germany | Pediatric Office | Düsseldorf | |
Germany | Pediatric Office | Kehl | |
Germany | Pediatric Office | Mülheim an der Ruhr | |
Italy | Pediatric office | Alba | Piemonte |
Italy | Pediatric office | Borgone | Piemonte |
Italy | Pediatric office | Carmagnola | Piemonte |
Italy | Pediatric Office | Condove | Piemonte |
Italy | Pediatric office | Mondovi | Piemonte |
Italy | Pediatric office | San Mauro Torinese | Piemonte |
Italy | Pediatric office | Torino | Piemonte |
Italy | Pediatric office | Torino | Piemonte |
Italy | Pediatric Office | Torino | Piemonte |
Italy | Pediatric Office | Torino | Piemonte |
Italy | Pediatric office | Torino | Piemonte |
Italy | Pediatric office | Torino | Piemonte |
Italy | Pediatric office | Turin | Piemonte |
Italy | Pediatric Office | Volpiano | Piemonte |
Italy | Pediatric Office | Volvera | Piemonte |
Lead Sponsor | Collaborator |
---|---|
HiPP GmbH & Co. Vertrieb KG |
Germany, Italy,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | daily total crying time | evaluation of the difference in the average reduction of daily crying time after 28 days of intervention between treatment and control group | 28 days | |
Secondary | growth parameters | determination of body weight, length, head circumference | 90 days | |
Secondary | tolerance evaluated by stool characteristics, gastrointestinal disorders and side effects | stool characteristics: frequency, consistency and color; gastrointestinal disorders: regurgitation, obstipation; side effects: vomiting, diarrhea, skin reactions | 28 days | |
Secondary | formula intake | evaluation of average daily drinking amount and formula acceptance | 28 days | |
Secondary | intestinal microbiota | evaluation of changes in the composition of the intestinal microbiota (Lactobacilli, Bifidobacteria, Coliforms) after intervention | 0-28 days |
Status | Clinical Trial | Phase | |
---|---|---|---|
Terminated |
NCT00954759 -
The Effect of Chiropractic Treatment on Infantile Colic A Randomized, Controlled Trial
|
N/A | |
Completed |
NCT01513304 -
Chiropractic Manual Therapy in Infantile Colic
|
N/A | |
Recruiting |
NCT02695784 -
Probiotics After Discharge
|
Phase 4 | |
Completed |
NCT04374955 -
The Effect of Probiotic Added to Maternal Diet on Infantile Colic and Intestinal Microbiota Content
|
N/A | |
Terminated |
NCT03329222 -
An Infant Formula Trial on Dietary Management of Infantile Colic
|
N/A | |
Not yet recruiting |
NCT06462651 -
Effect of Probiotic Limosilactobacillus Reuteri (L. Reuteri) on Crying and Fussing Time in Infants With Colic
|
N/A | |
Withdrawn |
NCT01887444 -
Lactobacillus Reuteri Supplementation in the Treatment of Infantile Colic
|
N/A | |
Completed |
NCT04632888 -
The Effect of Telephone Support for Breastfeeding Follow-up on Infantile Colic and Maternal Breastfeeding Self-efficacy
|
N/A | |
Active, not recruiting |
NCT06299358 -
Interventional Practices and Their Effectiveness in Infants With İnfantyl Colic
|
N/A | |
Completed |
NCT02988791 -
Evaluation of a Probiotic (Bifidobacterium in the Treatment of Infantile Colic (IC)
|
N/A | |
Completed |
NCT02595515 -
The Effect of Chiropractic Treatment of Infantile Colic
|
N/A | |
Completed |
NCT01258153 -
Preliminary Efficacy and Safety Study of Oral Nepadutant in Infant Colic
|
Phase 2 | |
Completed |
NCT03434249 -
Clinical Trial to Evaluate the Efficacy of Bifidobacterium BB-12® in the Treatment of Infantile Colic
|
N/A | |
Not yet recruiting |
NCT02430831 -
Effect of Milk Formula Supplemented With L. Reuteri on Crying Time in Colicky Infants Less Than 3 Months Old
|
Phase 4 | |
Not yet recruiting |
NCT02094092 -
Role of ProTectis on Infant Colic and Its Effect on Infant Crying Time and Maternal Mental Health
|
N/A | |
Terminated |
NCT03477669 -
Infantile Colic: Study of the Efficacy of Lactobacillus GG (ATCC 53103) Plus Chamomile in Breastfeeding Infants
|
N/A | |
Completed |
NCT04262648 -
Randomized Placebo-controlled Study of L. Reuteri NCIMB 30351 in GI Functional Disorders and Food Allergy in Newborns
|
N/A | |
Completed |
NCT05244291 -
Effect of Therapeutic Touch at Different Times on Infantile Colic According to Watson's Theory
|
N/A | |
Not yet recruiting |
NCT06197100 -
Supportive Care Training Given to Mothers of Babies With Infants Colic
|
N/A | |
Terminated |
NCT02138656 -
CHiropractic for Infantile Colic Study
|
N/A |